Computational identification and validation of novel inhibitors targeting LLM genes in Staphylococcus aureus for antimicrobial drug development

Authors

  • Ayodeji A. Fakuade Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomosho, Oyo State, Nigeria Author
    • Iyanuoluwa H. Adetunji Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomosho, Oyo State, Nigeria Author
      • Adedamola O. Adesina Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomosho, Oyo State, Nigeria Author
        • Emmanuel A. Olabiyi Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomosho, Oyo State, Nigeria Author
          • Oluwadamilola V. Ojo Department of Biochemistry, Olusegun Agagu University of Science and Technology, Ondo State, Nigeria Author
            • Ridwan O. Muraina Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomosho, Oyo State, Nigeria Author

              DOI:

              https://doi.org/10.33003/chemclass-2026-1002/08

              Keywords:

              Staphylococcus aureus; LLM gene; Molecular docking; Molecular dynamics simulations; Virtual screening; Pharmacophore modelling

              Abstract

              Staphylococcus aureus is a formidable pathogen responsible for a wide variety of illnesses, including some that are resistant to several antibiotics. Targeting the key llm genes in S. aureus, which are crucial for bacterial lysis and methicillin resistance, is an attractive method for accelerating the development of novel antimicrobial drugs. The aim of this research is to computationally find and validate novel inhibitors targeting these llm genes to combat S. aureus infections. An in-silico investigation was done using a complete literature review on NCBI and genomic analysis to uncover the llm genes in the S. aureus genome. Using computational techniques, including molecular docking using AutoDock Tools and PERL, twenty-two ligands, including the standard drug (Tunicamycin), were docked against the active site of the llm gene-encoded protein receptor. Pharmacokinetic investigations and molecular docking studies showed six potential inhibitors: ZINC06605913, ZINC06905586, ZINC35022243, ZINC40483738, ZINC90417652, and ZINC85428484. Molecular dynamics simulations (MDS) using GROMACS were performed on the molecules (ZINC90417652) with the highest binding affinity to examine the dynamics and stability of the protein-ligand complex. The predicted inhibitor demonstrated good pharmacological and structural properties, underscoring it’s potential as an effective antibacterial medications compare to tunicamycin. This study underscores the effectiveness of computational techniques in the identification and validation of novel inhibitors, providing a firm platform for the development of new antimicrobial medications targeting the llm genes in Staphylococcus aureus.

              Downloads

              Download data is not yet available.

              Downloads

              Published

              2026-06-30

              Issue

              Section

              Original Research Articles

              How to Cite

              Computational identification and validation of novel inhibitors targeting LLM genes in Staphylococcus aureus for antimicrobial drug development. (2026). ChemClass Journal, 10(2), 50-63. https://doi.org/10.33003/chemclass-2026-1002/08

              Share

              Similar Articles

              21-30 of 53

              You may also start an advanced similarity search for this article.